Apr 19, 2023 / 05:30PM GMT
Gil Blum - Needham & Company, LLC - Analyst
Thank you for joining me in the third day of the Needham & Company healthcare conference. My name is Gil Blum, and I'm a senior biotech analyst here at Needham & Company. It is my pleasure to have with me today, Brian Sullivan, the Chairperson and CEO of Celcuity.
As a reminder, any viewers who are watching through our conference portal are able to submit questions via the ask-a-question box below the video feed window. And with that, Brian, you have the floor.
Brian Sullivan - Celcuity Inc. - CEO & Co-Founder
Great. Well, thank you, Gil. And thank you, all, for attending the conference and attending this presentation. What I'd like to do is just give you a little background on the company and how we got into drug development business and then review data and the study design of an ongoing Phase 3 study that we have.
Well, I started the company about 10 years ago with our Chief Science Officer, with the goal of developing a new cellular analysis platform. Essentially, we had developed
Celcuity Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 19, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers